Immediate-access Arteriovenous Versus Standard Arteriovenous Grafts in Hemodialysis Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

477 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-08-15

Study Completion Date

2020-04-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Arteriovenous fistulae (AVF) are considered the main access for hemodialysis (HD). Arteriovenous grafts (AVGs) are an alternative access modality in patients with exhausted native venous access. Immediate-access arteriovenous grafts (IAAVGs) is a new modality in which dialysis can be started immediately to avoid complications of central venous catheters.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Access Flow Based Intervention for Management of Arteriovenous Hemodialysis Access Dysfunction.

NCT02628119

Hemodialysis Arteriovenous Fistula Maturation Failure

UNKNOWN NA

Comparing Surgical and Endovascular Arteriovenous Fistula Creation

NCT05654103

End Stage Renal Disease on Dialysis

RECRUITING NA

Hemodialysis in the Elderly (70yrs & Older)

NCT03065972

Kidney Disease Kidney Failure Chronic Kidney Disease

UNKNOWN NA

Breaking Down Care Process and Patient-level Barriers to Arteriovenous Access Creation Prior to Hemodialysis Initiation

NCT04032613

Chronic Kidney Disease Chronic Kidney Disease Requiring Chronic Dialysis

COMPLETED NA

Creating a Buttonhole Tunnel Track by Repeated Needling of the AV Fistula on the Same Day in Patients on Hemodialysis.

NCT03989141

End-stage Renal Disease (ESRD)

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study aimed to evaluate and compare patency rate and complications of standard arteriovenous grafts (SAVGs) and immediate-access arteriovenous grafts (IAAVGs) in end stage renal disease (ESRD) patients for one year after the intervention. Patients were randomly divided into two groups: SAVGs group and IAAVGs group. Patients with ESRD with no chance for native AVF were examined clinically and by duplex ultrasonography preoperatively. Follow up was for one year. Primary end points were the success rate, complications rate (hematoma, pseudo-aneurysm, graft site infection, systemic bacteremia), time of first cannulation. Secondary end points were primary and secondary patency within one year.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hemodialysis Access Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Immediate-access Arteriovenous Grafts

Immediate-access Arteriovenous Grafts as a vascular access for hemodialysis patients

Group Type EXPERIMENTAL

Arteriovenous Grafts

Intervention Type PROCEDURE

Arteriovenous fistulae (AVF) are considered the main access for hemodialysis (HD). Arteriovenous grafts (AVGs) are an alternative access modality in patients with exhausted native venous access. Immediate-access arteriovenous grafts (IAAVGs) is a new modality in which dialysis can be started immediately to avoid complications of central venous catheters.

Standard Arteriovenous Grafts

Standard Arteriovenous Grafts as a vascular access for hemodialysis patients

Group Type ACTIVE_COMPARATOR

Arteriovenous Grafts

Intervention Type PROCEDURE

Arteriovenous fistulae (AVF) are considered the main access for hemodialysis (HD). Arteriovenous grafts (AVGs) are an alternative access modality in patients with exhausted native venous access. Immediate-access arteriovenous grafts (IAAVGs) is a new modality in which dialysis can be started immediately to avoid complications of central venous catheters.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Arteriovenous Grafts

Arteriovenous fistulae (AVF) are considered the main access for hemodialysis (HD). Arteriovenous grafts (AVGs) are an alternative access modality in patients with exhausted native venous access. Immediate-access arteriovenous grafts (IAAVGs) is a new modality in which dialysis can be started immediately to avoid complications of central venous catheters.

Intervention Type PROCEDURE